Law360 (March 8, 2006, 12:00 AM EST) -- U.S. Pharmaceutical giant Pfizer Inc. is taking on the Philippines to protect patents that cover its second best-selling drug Norvasc, only one month after a sweeping victory in U.S. courts cleared generic opposition.
Starting a new round of international litigation, Pfizer sued the Filipino government to prevent the nation from importing from India and Pakistan generic versions of the popular hypertension drug.
Pfizer filed the civil lawsuit in the Philippines after it learned that a government-owned importer and a local regulatory body allegedly planned to import unauthorized copies of the drug from suspected infringing manufacturers.
However, government officials insisted they had...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!